Regencell Bioscience Holdings Ltd (NASDAQ: RGC) is 48630.77% higher on its value in year-to-date trading and has touched a low of $0.08 and a high of $83.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RGC stock was last observed hovering at around $78.00 in the last trading session, with the day’s loss setting it -14.65%.
Currently trading at $63.35, the stock is 166.17% and 435.51% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.7 million and changing -18.78% at the moment leaves the stock 1927.98% off its SMA200. RGC registered 51119.15% gain for a year compared to 6-month gain of 45065.10%.
The stock witnessed a 583.86% loss in the last 1 month and extending the period to 3 months gives it a 7723.53%, and is 286.65% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 69.44% over the week and 33.20% over the month.
Regencell Bioscience Holdings Ltd (RGC) has around 12 employees, a market worth around $31.33B and $0.00M in sales. Distance from 52-week low is 79348.84% and -24.22% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.18%).
The shares outstanding are 494.49M, and float is at 30.48M with Short Float at 2.50%.
The top institutional shareholder in the company is UBS GROUP AG with over 312.0 shares valued at $1048.0. The investor’s holdings represent 0.0024 of the RGC Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 238.0 shares valued at $800.0 to account for 0.0018 of the shares outstanding.
